Solid Tumors
Solid tumors are abnormal masses of tissue that can occur in various organs of the body, such as the lungs, breast, or colon, and can be benign (non-cancerous) or malignant (cancerous).
Solid Tumors: MCLA-128 Treatment Study
We are studying a new bispecific antibody, MCLA-128, in patients with solid tumors that have an NRG1 fusion. The goal is to evaluate its safety and how well it may work against these tumors.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Are you pregnant or breastfeeding?
- Do you have any active uncontrolled infections or unexplained fever over 100.4°F (38.5°C)?
- Do you have any known heart problems, such as a history of heart attack or heart failure?
- Are you currently taking any medications that affect your immune system, like steroids or chemotherapy?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Mcla-128
Zenocutuzumab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
SCRI CCCIT Ges.m.b.H.
Uniklinikum Salzburg
Salzburg, Austria
UZ Leuven
Gastroenterology, Oncology
Heverlee, Belgium
Copenhagen University Hospital
Oncology
Copenhagen, Denmark
Sponsor: Partner Therapeutics Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.